- Home
- VCEL vs INSW Comparison
VCEL vs INSW Comparison
Compare VCEL & INSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- INSW
- Stock Information
- Founded
- VCEL 1989
- INSW 1999
- Country
- VCEL United States
- INSW United States
- Employees
- VCEL N/A
- INSW N/A
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- INSW Semiconductors
- Sector
- VCEL Health Care
- INSW Technology
- Exchange
- VCEL Nasdaq
- INSW Nasdaq
- Market Cap
- VCEL 2.1B
- INSW 2.3B
- IPO Year
- VCEL 1997
- INSW N/A
- Fundamental
- Price
- VCEL $30.21
- INSW $48.43
- Analyst Decision
- VCEL Strong Buy
- INSW Buy
- Analyst Count
- VCEL 6
- INSW 2
- Target Price
- VCEL $60.60
- INSW $52.00
- AVG Volume (30 Days)
- VCEL 811.4K
- INSW 505.2K
- Earning Date
- VCEL 11-06-2025
- INSW 11-06-2025
- Dividend Yield
- VCEL N/A
- INSW 6.67%
- EPS Growth
- VCEL 2045.40
- INSW N/A
- EPS
- VCEL 0.13
- INSW 4.81
- Revenue
- VCEL $249,119,000.00
- INSW $798,838,000.00
- Revenue This Year
- VCEL $18.35
- INSW N/A
- Revenue Next Year
- VCEL $22.47
- INSW $4.49
- P/E Ratio
- VCEL $224.93
- INSW $10.17
- Revenue Growth
- VCEL 16.13
- INSW N/A
- 52 Week Low
- VCEL $29.94
- INSW $27.20
- 52 Week High
- VCEL $63.00
- INSW $54.84
- Technical
- Relative Strength Index (RSI)
- VCEL 36.63
- INSW 65.25
- Support Level
- VCEL $29.93
- INSW $48.19
- Resistance Level
- VCEL $33.25
- INSW $49.83
- Average True Range (ATR)
- VCEL 1.64
- INSW 1.09
- MACD
- VCEL -0.25
- INSW 0.11
- Stochastic Oscillator
- VCEL 4.07
- INSW 73.90
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About INSW International Seaways Inc.
International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. The fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.